CORT - Corcept Therapeutics GAAP EPS of $0.30 revenue of $101.7M November, 03 2022 05:23 PM Corcept Therapeutics Incorporated Corcept Therapeutics press release ( NASDAQ: CORT ): Q3 GAAP EPS of $0.30. Revenue of $101.7M (+5.8% Y/Y). Shares -2.81% . For further details see: Corcept Therapeutics GAAP EPS of $0.30, revenue of $101.7M